Glucotrack Converts $600K Debt to Equity, Issuing 895K Shares
GCTK is trading near its 52-week low of $0.619 (15% above the low).
Summary
Glucotrack, Inc. converted $600,000 of debt into 895,000 common shares, significantly diluting existing equity but reducing its outstanding debt.
Key Events · Financing and Capital Events · GCTK
-
Debt-to-Equity Conversion
Glucotrack, Inc. entered an Exchange Agreement on April 13, 2026, to convert a $600,000 portion of an existing promissory note into common stock.
-
Significant Share Issuance
The company issued 895,000 shares of common stock to an investor in exchange for the cancellation of the $600,000 note, with no additional cash consideration.
-
Beneficial Ownership Limitation
The share issuance is subject to a 19.9% beneficial ownership limitation, potentially leading to tranches of issuance to comply with the restriction.
Analysis · GCTK · Industrial Applications And Services
Glucotrack, Inc. has entered into an Exchange Agreement to convert $600,000 of an existing promissory note into 895,000 shares of common stock. This transaction, while reducing the company's debt burden, results in substantial dilution for existing shareholders. The conversion price of approximately $0.67 per share is at a slight discount to the current market price. This move is a critical step for the micro-cap company to manage its balance sheet and extend its financial runway, but investors should note the significant increase in outstanding shares.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 35.3% of the 1492 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GCTK was trading at $0.71 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.4M. The 52-week trading range was $0.62 to $15.90. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.